List of Contents

Agricultural Biotechnology Market Size, Share, and Trends 2024 to 2034

Agricultural Biotechnology Market (By Application: Vaccine Development, Transgenic Crops & Animals, Antibiotic Development, Nutritional Supplements, Flower Culturing, Biofuels; By Organism Type: Plants, Animals, Microbes; By Type: Hybrid Seeds, Transgenic Crops, Bio-pesticides, Bio-fertilizers; By Technology: Genetic Engineering, Tissue Culture, Embryo Rescue, Somatic Hybridization, Molecular Diagnostics) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2034

  • Last Updated : July 2024
  • Report Code : 2890
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Agricultural Biotechnology Market 

5.1. COVID-19 Landscape: Agricultural Biotechnology Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Agricultural Biotechnology Market, By Application

8.1. Agricultural Biotechnology Market, by Application, 2024-2034

8.1.1. Vaccine Development

8.1.1.1. Market Revenue and Forecast (2021-2034)

8.1.2. Transgenic Crops & Animals

8.1.2.1. Market Revenue and Forecast (2021-2034)

8.1.3. Antibiotic Development

8.1.3.1. Market Revenue and Forecast (2021-2034)

8.1.4. Nutritional Supplements

8.1.4.1. Market Revenue and Forecast (2021-2034)

8.1.5. Flower Culturing

8.1.5.1. Market Revenue and Forecast (2021-2034)

8.1.6. Biofuels

8.1.6.1. Market Revenue and Forecast (2021-2034)

Chapter 9. Global Agricultural Biotechnology Market, By Organism Type

9.1. Agricultural Biotechnology Market, by Organism Type, 2024-2034

9.1.1. Plants

9.1.1.1. Market Revenue and Forecast (2021-2034)

9.1.2. Animals

9.1.2.1. Market Revenue and Forecast (2021-2034)

9.1.3. Microbes

9.1.3.1. Market Revenue and Forecast (2021-2034)

Chapter 10. Global Agricultural Biotechnology Market, By Type 

10.1. Agricultural Biotechnology Market, by Type, 2024-2034

10.1.1. Hybrid Seeds

10.1.1.1. Market Revenue and Forecast (2021-2034)

10.1.2. Transgenic Crops

10.1.2.1. Market Revenue and Forecast (2021-2034)

10.1.3. Bio-pesticides

10.1.3.1. Market Revenue and Forecast (2021-2034)

10.1.4. Bio-fertilizers

10.1.4.1. Market Revenue and Forecast (2021-2034)

Chapter 11. Global Agricultural Biotechnology Market, By Technology 

11.1. Agricultural Biotechnology Market, by Technology, 2024-2034

11.1.1. Genetic Engineering

11.1.1.1. Market Revenue and Forecast (2021-2034)

11.1.2. Tissue Culture

11.1.2.1. Market Revenue and Forecast (2021-2034)

11.1.3. Embryo Rescue

11.1.3.1. Market Revenue and Forecast (2021-2034)

11.1.4. Somatic Hybridization

11.1.4.1. Market Revenue and Forecast (2021-2034)

11.1.5. Molecular Diagnostics

11.1.5.1. Market Revenue and Forecast (2021-2034)

11.1.6. Vaccine

11.1.6.1. Market Revenue and Forecast (2021-2034)

11.1.7. Others

11.1.7.1. Market Revenue and Forecast (2021-2034)

Chapter 12. Global Agricultural Biotechnology Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Application (2021-2034)

12.1.2. Market Revenue and Forecast, by Organism Type (2021-2034)

12.1.3. Market Revenue and Forecast, by Type (2021-2034)

12.1.4. Market Revenue and Forecast, by Technology (2021-2034)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Application (2021-2034)

12.1.5.2. Market Revenue and Forecast, by Organism Type (2021-2034)

12.1.5.3. Market Revenue and Forecast, by Type (2021-2034)

12.1.5.4. Market Revenue and Forecast, by Technology (2021-2034)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Application (2021-2034)

12.1.6.2. Market Revenue and Forecast, by Organism Type (2021-2034)

12.1.6.3. Market Revenue and Forecast, by Type (2021-2034)

12.1.6.4. Market Revenue and Forecast, by Technology (2021-2034)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Application (2021-2034)

12.2.2. Market Revenue and Forecast, by Organism Type (2021-2034)

12.2.3. Market Revenue and Forecast, by Type (2021-2034)

12.2.4. Market Revenue and Forecast, by Technology (2021-2034)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Application (2021-2034)

12.2.5.2. Market Revenue and Forecast, by Organism Type (2021-2034)

12.2.5.3. Market Revenue and Forecast, by Type (2021-2034)

12.2.5.4. Market Revenue and Forecast, by Technology (2021-2034)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Application (2021-2034)

12.2.6.2. Market Revenue and Forecast, by Organism Type (2021-2034)

12.2.6.3. Market Revenue and Forecast, by Type (2021-2034)

12.2.6.4. Market Revenue and Forecast, by Technology (2021-2034)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Application (2021-2034)

12.2.7.2. Market Revenue and Forecast, by Organism Type (2021-2034)

12.2.7.3. Market Revenue and Forecast, by Type (2021-2034)

12.2.7.4. Market Revenue and Forecast, by Technology (2021-2034)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Application (2021-2034)

12.2.8.2. Market Revenue and Forecast, by Organism Type (2021-2034)

12.2.8.3. Market Revenue and Forecast, by Type (2021-2034)

12.2.8.4. Market Revenue and Forecast, by Technology (2021-2034)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Application (2021-2034)

12.3.2. Market Revenue and Forecast, by Organism Type (2021-2034)

12.3.3. Market Revenue and Forecast, by Type (2021-2034)

12.3.4. Market Revenue and Forecast, by Technology (2021-2034)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Application (2021-2034)

12.3.5.2. Market Revenue and Forecast, by Organism Type (2021-2034)

12.3.5.3. Market Revenue and Forecast, by Type (2021-2034)

12.3.5.4. Market Revenue and Forecast, by Technology (2021-2034)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Application (2021-2034)

12.3.6.2. Market Revenue and Forecast, by Organism Type (2021-2034)

12.3.6.3. Market Revenue and Forecast, by Type (2021-2034)

12.3.6.4. Market Revenue and Forecast, by Technology (2021-2034)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Application (2021-2034)

12.3.7.2. Market Revenue and Forecast, by Organism Type (2021-2034)

12.3.7.3. Market Revenue and Forecast, by Type (2021-2034)

12.3.7.4. Market Revenue and Forecast, by Technology (2021-2034)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Application (2021-2034)

12.3.8.2. Market Revenue and Forecast, by Organism Type (2021-2034)

12.3.8.3. Market Revenue and Forecast, by Type (2021-2034)

12.3.8.4. Market Revenue and Forecast, by Technology (2021-2034)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Application (2021-2034)

12.4.2. Market Revenue and Forecast, by Organism Type (2021-2034)

12.4.3. Market Revenue and Forecast, by Type (2021-2034)

12.4.4. Market Revenue and Forecast, by Technology (2021-2034)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Application (2021-2034)

12.4.5.2. Market Revenue and Forecast, by Organism Type (2021-2034)

12.4.5.3. Market Revenue and Forecast, by Type (2021-2034)

12.4.5.4. Market Revenue and Forecast, by Technology (2021-2034)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Application (2021-2034)

12.4.6.2. Market Revenue and Forecast, by Organism Type (2021-2034)

12.4.6.3. Market Revenue and Forecast, by Type (2021-2034)

12.4.6.4. Market Revenue and Forecast, by Technology (2021-2034)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Application (2021-2034)

12.4.7.2. Market Revenue and Forecast, by Organism Type (2021-2034)

12.4.7.3. Market Revenue and Forecast, by Type (2021-2034)

12.4.7.4. Market Revenue and Forecast, by Technology (2021-2034)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Application (2021-2034)

12.4.8.2. Market Revenue and Forecast, by Organism Type (2021-2034)

12.4.8.3. Market Revenue and Forecast, by Type (2021-2034)

12.4.8.4. Market Revenue and Forecast, by Technology (2021-2034)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Application (2021-2034)

12.5.2. Market Revenue and Forecast, by Organism Type (2021-2034)

12.5.3. Market Revenue and Forecast, by Type (2021-2034)

12.5.4. Market Revenue and Forecast, by Technology (2021-2034)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Application (2021-2034)

12.5.5.2. Market Revenue and Forecast, by Organism Type (2021-2034)

12.5.5.3. Market Revenue and Forecast, by Type (2021-2034)

12.5.5.4. Market Revenue and Forecast, by Technology (2021-2034)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Application (2021-2034)

12.5.6.2. Market Revenue and Forecast, by Organism Type (2021-2034)

12.5.6.3. Market Revenue and Forecast, by Type (2021-2034)

12.5.6.4. Market Revenue and Forecast, by Technology (2021-2034)

Chapter 13. Company Profiles

13.1. ADAMA Ltd

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Bayer AG

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. ChemChina

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Corteva

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Evogene Ltd.

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. KWS SAAT SE & Co. KGaA

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Limagrain

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Marrone Bio Innovations

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. MITSUI & CO., LTD

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Nufarm

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Proceed To Buy

USD 4900
USD 3800
USD 2100
USD 2100
USD 7500
Immediate Delivery Available

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client

down-arrow-imgGet a Sample

Connect with us now; your solution awaits on the other side!

Contact Us